Implications of SMAD4 Genetic Status in Recurrent Pancreatic Adenocarcinoma

被引：0
作者：
AlMasri, S. S. [1 ]
Zenati, M. [1 ]
Singhi, A. D. [1 ]
Lee, K. K. [1 ]
Bahary, N. [1 ]
Bartlett, D. [1 ]
Zureikat, A. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Surg Oncol, Pittsburgh, PA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
71
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
[31]   Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis [J].
Inoue, H ;
Furukawa, T ;
Sunamura, M ;
Takeda, K ;
Matsuno, S ;
Horii, A .
GENES CHROMOSOMES & CANCER, 2001, 31 (03) :295-299
[32]   Frequent loss of heterozygosity of SMAD4 locus and prognostic impacts of SMAD4 immunohistochemistry in gastric adenocarcinoma with enteroblastic differentiation [J].
Yatagai, Noboru ;
Saito, Tsuyoshi ;
Akazawa, Yoichi ;
Hayashi, Takuo ;
Yanai, Yuka ;
Tsuyama, Sho ;
Murakami, Takashi ;
Ueyama, Hiroya ;
Watanabe, Sumio ;
Nagahara, Akihito ;
Yao, Takashi .
HUMAN PATHOLOGY, 2019, 88 :18-26
[33]   Smad4 is Associated With Differentiation of Pancreatic Ductal Adenocarcinomas [J].
Izumi, S. ;
Ichihara, S. ;
Kubo, T. ;
Ohtani, H. ;
Yano, M. ;
Tanaka, N. ;
Ohashi, R. ;
Onoda, Y. ;
Suzuka, I. .
PANCREAS, 2014, 43 (08) :1369-1369
[34]   Prognostic value of SMAD4 in resectable pancreatic cancer [J].
Su, Hui ;
Wang, Cunchuan .
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2022, 76 (01) :324-332
[35]   Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4 [J].
Masetti, Michele ;
Acquaviva, Giorgia ;
Visani, Michela ;
Tallini, Giovanni ;
Fornelli, Adele ;
Ragazzi, Moira ;
Vasuri, Francesco ;
Grifoni, Daniela ;
Di Giacomo, Simone ;
Fiorino, Sirio ;
Lombardi, Raffaele ;
Tuminati, David ;
Ravaioli, Matteo ;
Fabbri, Carlo ;
Bacchi-Reggiani, Maria Letizia ;
Pession, Annalisa ;
Jovine, Elio ;
de Biase, Dario .
CANCER BIOMARKERS, 2018, 21 (02) :323-334
[36]   The utility of SMAD4 as a diagnostic immunohistochernical marker for pancreatic adenocarcinoma, and its expression in other solid tumors [J].
Siddiqui, M. T. ;
Cohen, C. .
MODERN PATHOLOGY, 2007, 20 :84A-84A
[37]   The Role of SMAD4 Inactivation in Epithelial-Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link? [J].
Racu, Marie-Lucie ;
Lebrun, Laetitia ;
Schiavo, Andrea Alex ;
Van Campenhout, Claude ;
De Clercq, Sarah ;
Absil, Lara ;
Minguijon Perez, Esmeralda ;
Maris, Calliope ;
Decaestecker, Christine ;
Salmon, Isabelle ;
D'Haene, Nicky .
CANCERS, 2022, 14 (04)
[38]   Poorly differentiated histologic grade correlates with worse survival in SMAD4 negative pancreatic adenocarcinoma patients [J].
Park, Joon Y. ;
King, Jonathan ;
Reber, Howard ;
Joe Hines, Oscar ;
Mederos, Michael A. ;
Wang, Hanlin L. ;
Dawson, David ;
Wainberg, Zev ;
Donahue, Timothy ;
Girgis, Mark .
JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (02) :389-398
[39]   The utility of SMAD4 as a diagnostic immunohistochemical marker for pancreatic adenocarcinoma, and its expression in other solid tumors [J].
Ali, Sarfraz ;
Cohen, Cynthia ;
Little, James V. ;
Sequeira, Judy H. ;
Mosunjac, Marina B. ;
Siddiqui, Momin T. .
DIAGNOSTIC CYTOPATHOLOGY, 2007, 35 (10) :644-648
[40]   Utility of SMAD4 as a diagnostic immunohistochemical marker for pancreatic adenocarcinoma, and its expression in other solid tumors [J].
Siddiqui, M. T. ;
Cohen, C. .
LABORATORY INVESTIGATION, 2007, 87 :84A-84A
12345